The eyelid tumor in Yogyakarta, Indonesia

Agus Supartoto; Annisa Nurina Ayuningtyas; Banu Aji Dibyasakti; Purjanto Tepo Utomo; Datu Respatika; Muhammad Bayu Sasongko

doi:10.19106/JMedSci005103201906

The eyelid tumor in Yogyakarta, Indonesia

https://doi.org/10.19106/JMedSci005103201906

Agus Supartoto^(1*), Annisa Nurina Ayuningtyas⁽²⁾, Banu Aji Dibyasakti⁽³⁾, Purjanto Tepo Utomo⁽⁴⁾, Datu Respatika⁽⁵⁾, Muhammad Bayu Sasongko⁽⁶⁾

(1) Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(2) Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(3) Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(4) Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(5) Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(6) Department of Ophthalmology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author

Abstract

Many types of eyelid tumors may easily be diagnosed from a clinical point of view. However only a small number of large studies exist exploring the frequency of eyelid lesions from different regions. According to the epidemiology of various eyelid lesions happened in Yogyakarta Special Region, this study was aimed to investigate the prevalence of eyelid tumors in Yogyakarta Special Region. A total of 94 patients were enrolled in a descriptive study. The data were taken retrospectively from the medical record. All patients were diagnosed with eyelid tumors from January 2014 until December 2017 by histopathological examination. Among the subjects, 56 (59.6%) were male and 38 (40.4%) were female. There was no difference found in laterality (OD 46% vs OS 50%). Sebaceous carcinoma was found in 15 (16%) patients, followed by squamous cell carcinoma (SCC) 13 (13.8%), basal cell carcinoma (BCC) 11 (11.7%), epidermoid cyst 7 (7.4%), non-Hodgkin lymphoma 7 (7.4%), and others. We also found that 11 (11.7%) of patients showed an inflammation appearance only. The therapy was varied from extirpation and biopsy (39.4%), wide excision (27.7%), excision and biopsy (18.1%), exenteration (10.6%), and also anterior and lateral orbitotomy (2.1%) for each procedure. The eyelid tumor was found equally in the right and the left eye. Sebaceous carcinoma followed by SCC and BCC were the most common eyelid tumor found in this study. A further study is needed to determine the risk factor of each tumor.

Keywords

eyelid tumor; sebaceous carcinoma; squamous cell carcinoma; basal cell carcinoma

Full Text:

PDF

References

Silverman N, Shinder R. What’s New in Eyelid Tumors. Asia Pac J Ophthalmol 2017;6(2):143-52.
Ho M, Liu DT, Chong KK, Ng H, Lam DS. Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience. Hong Kong Med J 2013;19(2):150-5. https://doi.org/10.12809/hkmj134040
Deprez M, Uffer S. Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature. Am J Dermatopath. 2009;31(3):256-62. https://doi.org/10.1097/DAD.0b013e3181961861
Pe’er J. Pathology of eyelid tumors. Indian J Ophthalmol 2016;64(3):177. https://doi.org/10.4103/0301-4738.181752
Coroi MC, Roşca E, Muţiu G, Coroi T, Bonta M. Eyelid tumors: histopathological and clinical study performed in County Hospital of Oradea between. Rom J Morphol Embryo 2010;51(1):111-5.
Yin VT, Merritt HA, Sniegowski M, Esmaeli B. Eyelid and ocular surface carcinoma: diagnosis and management. Clin Dermatol 2015;33(2):159-69. https://doi.org/10.1016/j.clindermatol.2014.10.008
Bagheri A, Tavakoli M, Kanaani A, Zavareh RB, Esfandiari H, Aletaha M, et al. Eyelid masses: A 10-year survey from a tertiary eye hospital in Tehran. Middle East Afr J Ophthalmol 2013;20(3):187. https://doi.org/10.4103/0974-9233.114788
Bălăşoiu A, Mănescu M, Bălăşoiu M, Avrămoiu I, Pirici I, Burcea M, et al. Histological and immunohistochemical study of the eyelid basal cell carcinomas. Rom J Morphol Embryo 2015;56(2 Suppl):803-10.
Mohan BP, Letha V. Profile of eye lid lesions over a decade: a histopathological study from a tertiary care center in South India. Int J Adv Med 2017;4(5):1406-11. https://doi.org/10.18203/2349-3933.ijam20174293
Anandani GM, Parikh SB, Shah NR. Histopathological Study of Eyelid Lesions. Natl Lab Med 2018; 7(1):007-11.
Ford J, Thakar S, Thuro B, Esmaeli B. Prognostic value of the staging system for eyelid tumors in the 7th edition of the American Joint Committee on Cancer Staging Manual. Ophthal Plast Reconstr Surg 2017;33(5):317-24. https://doi.org/10.1097/IOP.0000000000000901
Yu S-S, Zhao Y, Zhao H, Lin J-Y, Tang X. A retrospective study of 2228 cases with eyelid tumors. Int J Ophthalmol 2018; 11(11):1835-41.
Paul S, Vo DT, Silkiss RZ. Malignant and benign eyelid lesions in San Francisco: study of a diverse urban population. Am J Clin Med 2011;8(1):40-6.
Pawar S, Sharma R, Mahapatra A, Lad S, Musa M. Choroid plexus papilloma of the posterior third ventricle during infancy & childhood: report of two cases with management morbidities. Neurol India 2003;51(3):379.
Supartoto A, Indrakila S, Pardawan. Clinical aspect and management of basal cell carsinoma. J Med Sci 2004;36(3):167-71.
Gupta P, Gupta RC, Khan L. Profile of eyelid malignancy in a Tertiary Health Care Center in North India. J Cancer Res Ther 2017;13(3):484.

DOI: https://doi.org/10.19106/JMedSci005103201906

Article Metrics

Abstract views : 1554 |

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

View My Stats

Journal of the Medical Sciences (Berkala Ilmu Kedokteran) by Universitas Gadjah Mada is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Based on a work at http://jurnal.ugm.ac.id/bik/.

Username
Password
Remember me